Gene: SEZ6L2
Official Full Name: seizure related 6 homolog like 2provided by HGNC
Gene Summary: This gene encodes a seizure-related protein that is localized on the cell surface. The gene is located in a region of chromosome 16p11.2 that is thought to contain candidate genes for autism spectrum disorders (ASD), though there is no evidence directly implicating this gene in ASD. Increased expression of this gene has been found in lung cancers, and the protein is therefore considered to be a novel prognostic marker for lung cancer. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28103 | SEZ6L2 Knockout cell line (HeLa) | Human | SEZ6L2 | 1:3~1:6 | Negative | Online Inquiry |
KO28104 | SEZ6L2 Knockout cell line (HCT 116) | Human | SEZ6L2 | 1:2~1:4 | Negative | Online Inquiry |
KO28105 | SEZ6L2 Knockout cell line (HEK293) | Human | SEZ6L2 | 1:3~1:6 | Negative | Online Inquiry |
KO28106 | SEZ6L2 Knockout cell line (A549) | Human | SEZ6L2 | 1:3~1:4 | Negative | Online Inquiry |
SEZ6L2 Gene Knockout Cell Lines are custom-engineered cellular models designed to specifically silence or eliminate the SEZ6L2 gene, which is believed to play a role in neurodevelopment and synaptic functions. These knockout cell lines utilize CRISPR-Cas9 technology to introduce precise mutations in the target gene, thereby allowing researchers to investigate the functional consequences of SEZ6L2 deficiency in a controlled environment.
The key mechanisms underlying the functionality of these cell lines involve the selective inactivation of SEZ6L2, enabling the exploration of its influence on cellular processes such as differentiation, proliferation, and response to external stimuli. By manipulating the expression of this gene, researchers can gain insights into the molecular pathways that are disrupted in various neurological disorders, thus contributing to a better understanding of their etiology.
The scientific importance of SEZ6L2 Gene Knockout Cell Lines extends into both academic and clinical research. In the academic realm, they serve as essential tools for studies focusing on synaptic plasticity and neurological pathways, while in clinical settings, these models may assist in identifying potential therapeutic targets for disorders linked to SEZ6L2 dysfunction, offering hope for novel treatment strategies.
What sets our SEZ6L2 knockout cell lines apart from alternatives is the high efficiency of gene editing and the reliability of our cell line models. Unlike conventional models that may offer variable results, our knockout lines have been rigorously validated to ensure consistent expression profiles and functional assays. This makes them a preferred choice for researchers seeking reproducibility in their findings.
For researchers and clinicians, utilizing SEZ6L2 Gene Knockout Cell Lines not only accelerates the pace of discovery but also enhances the accuracy of experimental results. The insights gained from these models can drive innovation in understanding complex biological systems and developing targeted interventions.
Our company specializes in providing high-quality biological products tailored for cutting-edge research. With extensive expertise in cell line development and gene editing technologies, we are committed to supporting the scientific community with reliable tools that empower discoveries and advancements in health sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.